Small Business Resources, Business Advice and Forms from AllBusiness.com

Israeli Biopharmaceutical Company Exploring The Idea Of A European IPO.

Peptor Ltd. an Israeli biopharmaceutical company is exploring the idea of an initial public offering (IPO) on the London or German Stock Exchange. Peptor sells most of its products in Europe and thinks its brand name exposure in Europe (should the IPO go ahead) will give its initial opening share price a boost. The company has appointed Nomura Securities as its investment banker. No

In addition, make sure to read these premium articles also available with your free trial:

T T T
art_print Printart_email Email 16x16-digg-guy  Digg It delicious-small  del.icio.us

Related Resources

Free AllBusiness Articles

  • Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations.
    • PALO ALTO, Calif. -- Affymax, Inc. (Nasdaq:AFFY) today announced that Robert F. Venteicher, Ph.D. has joined the company as vice president, Technical Operations. Dr. Venteicher has nearly 30 years of experience in pharmaceutical and biotechnology drug development. In this position, Dr. Venteicher will oversee manufacturing and process development, quality and ......
  • AVI BioPharma Chairman and CEO Resigns.
    • Jack L. Bowman named chairman; K. Michael Forrest named interim CEO PORTLAND, Ore. -- AVI BioPharma, Inc. (Nasdaq:AVII) today announced the resignation of Denis R. Burger, Ph.D., from his positions as chairman, chief executive officer and board member, effective immediately. Jack L. Bowman, the board's lead independent director, has been ......
  • The relationship between boards of directors and initial public offerings in the biotechnology industry.
    • One area that has been receiving increasing attention by scholars and practitioners in entrepreneurship is the board of directors and its relationship to initial public offerings (IPOs) and corporate performance. The relationship between boards of directors and corporate financial performance has been investigated over the past five decades in such ......
  • Filling the GAP: doing "reverse mergers" into shell companies has become a major avenue for private companies seeking new capital, but established practices like PIPEs and mezzanine financing have their...
    • At first glance, a sailing concern and a biotechnology company would seem to have little in common. But--talk about an odd couple--just such a business combination was consummated last March when, in San Diego, a biotechnology company joined forces with Global Yacht Services. After the merger, the yacht-chartering business, which ......
  • UK Biotech Firm Launches Program
    • HEADNOTE EUROPE GeneMedix, a UK-based biopharmaceutical company with operations in Europe and Asia, launched a Level I American depositary receipt program with Bank of New York as depositary. The company has joint London and Singapore stock exchange listings. One ADR is equivalent to one ordinary share. GeneMedix plans to file ......
  • Roche Acquires THP in $56.5 Million Deal.
    • MOUNTAIN VIEW, Calif. -- Roche, the world's largest biotechnology company, has acquired privately held biopharmaceutical company Therapeutic Human Polyclonals Inc. for $56.5 million. THP, a California-based company with a subsidiary in Germany, is focused on research in human antibody technologies. The company has developed a unique transgenic mammalian platform to ......
  • Signaling corporate strategy in IPO communication: astudy of biotechnology IPOs on the NASDAQ.
    • A clear corporate strategy communication can be a signal to financial analysts and public investors at the time of an initial public offering (IPO). This study examines IPO prospectuses of 57 biotechnology firms listed on the NASDAQ between 1997 and 2002. Using regression analysis, this article shows that the clarity, ......
Related Topics
Tools

Sponsored Links

Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy

Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.

Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.